Innovation networks in the biopharmaceutical sector: a study of UK small- and medium-sized enterprises

International Journal of Entrepreneurship and Innovation Management

Volumn 5, Issue 1-2, 2005, Pages 85-102

  Gurău, Călin ^a  

^a MONTPELLIER BUSINESS SCHOOL   (France)

Author keywords

innovation networks; SMEs; UK biopharmaceutical sector

Indexed keywords

EID: 34548576499     PISSN: 1368275X     EISSN: 17415098     Source Type: Journal    
DOI: 10.1504/ijeim.2005.006338     Document Type: Article

References (39)

1. Achaiya, R. (1998) ‘Conclusions: biotechnology and European competitiveness’, in J. Senker (Ed) Biotechnology and Competitive Advantage, Cheltenham: Edward Elgar, pp.156–163.
2. Acharya, R. (1999) The Emergence and Growth of Biotechnology, Cheltenham: Edward Elgar.
3. Alexandre, M.T., Furrer, O. and Sudharsan, D. (2003) ‘A hierarchical framework of new product development: an example from biotechnology’, European Journal of Innovation Management, Vol. 6, No. 1, pp.48–63.
4. Arias, J.T.G. (1995) ‘Do networks really foster innovation?’, Management Decision, Vol. 33, No. 9, pp.52–56.
5. Bartholomew, S. (1997) ‘National systems of biotechnology innovation: complex interdependencies in the global system’, Journal of International Business Studies, Vol. 28, No. 2, pp.241–267.
6. Baum, J.A.C., Calabrese, T. and Silverman, B.S. (2000) ‘Don’t go it alone: alliance network composition and startups’ performance in Canadian biotechnology’, Strategic Management Journal, Vol. 21, No. 3, pp.267–294.
7. Briggs, P.S. (1994) Biotechnology: A Commercial Evaluation, Richmond: Script Reports.
8. Chandrasekar, C.R., Helliar, C.V., Lonie, A.A., Nixon, W.A. and Power, D.M. (1999) ‘Strategic management of innovation risk in the biopharmaceutical industry: a UK perspective’, International Journal of Healthcare Technology and Management, Vol. 1, Nos. 1–2, pp.62–76.
9. Cumming, B.S. (1998) ‘Innovation overview and future challenges’, European Journal of Innovation Management, Vol. 1, No. 1, pp.21–29.
10. Deeds, D.L. and Hill, C.W.L. (1996) ‘Strategic alliances and the rate of new product development: an empirical study of entrepreneurial biotechnology firms’, Journal of Business Venturing, Vol. 11, No. 1, pp.41–55.
11. Dickson, K.E. and Hadjimanolis, A. (1998) ‘Innovation and networking amongst small manufacturing firms in Cyprus’, International Journal of Entrepreneurial Behaviour and Research, Vol. 4, No. 1, pp.5–17.
12. Dodgson, M. (1993) Technological Collaboration in Industry, London: Routledge.
13. Dorabjee, S., Lumley, C.E. and Cartwright, S. (1998) ‘Culture, innovation and successful development of new medicines – an exploratory study of the pharmaceutical industry’, Leadership and Organization Development Journal, Vol. 19, No. 4, pp.199–210.
14. Euromonitor (1988) The International Biotechnology Handbook, London: Euromonitor Publications.
15. Evans, A.G. and Varaiya, N.P. (2003) ‘Anne Evans: assessment of a biotechnology market opportunity’, Entrepreneurship: Theory and Practice, Vol. 28, No. 1, pp.87–106.
16. Fairtlough, G. (1996) ‘A marriage of large and small: R and D for healthcare products’, Business Strategy Review, Vol. 7, No. 2, pp.14–23.
17. Fontes, M. (2000) ‘The biotechnology cluster in Portugal’. Available at: http://www.centrim.bus.bton.ac.uk/open/we/do/proj/rise/risewp/clusters/clusterPT_biotech.pdf, [accessed March 2004].
18. Freeman, C. (1982) The Economics of Industrial Innovation, London: Frances Pinter.
19. Freeman, C. and Hagedoorn, J. (1994) ‘Catching up or falling behind: patterns in international inter-firm technology partnering’, World Development, Vol. 22, No. 5, pp.771–780.
20. Gulati, R. (1998) ‘Alliances and networks’, Strategic Management Journal, Vol. 9, No. 4, pp.293–317.
21. Hagedoorn, J. (1990) ‘Organizational modes of inter-firm cooperation and technology transfer’, Technovation, Vol. 10, No. 1, pp.17–30.
22. Liebeskind, J.P., Lumerman, A.O., Zucker, L. and Brewer, M. (1996) ‘Social networks, learning, and flexibilty: sourcing scientific knowledge in new biotechnology firms’, Organization Science, Vol. 7, No. 4, pp.428–443.
23. Lindman, M.T. (2002) ‘Open or closed strategy in developing new products? A case study of industrial NPD in SMEs’, European Journal of Innovation Management, Vol. 5, No. 4, pp.224–236.
24. Muller, A. and Välikangas, L. (2002) ‘Extending the boundary of corporate innovation’, Strategy and Leadership, Vol. 30, No. 3, pp.4–9.
25. Mytelka, L.K. (1999) ‘New trends in biotechnology networking’, International Journal of Biotechnology, Vol. 1, No. 1, pp.30–41.
26. Nilsson, A., Sandstr~m, A. and Pettersson, I. (2000) ‘Knowledge production and knowledge flows in the Swedish biotechnology innovation system’, Scientometrics, Vol. 48, No. 2, pp.179–201.
27. Persidis, A. (1996) ‘Building molecular value’, Journal of Business Strategy, Vol. 17, No. 2, pp.18–21.
28. Pisano, G.P. (1990) ‘The R&D boundaries of the firm: an empirical study’, Administrative Science Quarterly, Vol. 35, No. 1, pp.153–177.
29. Powell, W.W., Koput, K.W. and Smith-Doerr, L. (1996) ‘Interorganisational collaboration and the locus of innovation: networks of learning in biotechnology’, Administrative Science Quarterly, Vol. 41, No. 1, pp.116–146.
30. Pyka, A. (2002) ‘Innovation networks in economics: from the incentive-based to knowledge-based approaches’, European Journal of Innovation Management, Vol. 5, No. 3, pp.152–163.
31. Rafiq, M. and Saxon, T. (2000) ‘R&D and marketing integration in NPD in the pharmaceutical industry’, European Journal of Innovation Management, Vol. 3, No. 4, pp.222–231.
32. Roijakkers, A.H.W. (2003) Inter-Firm Cooperation in High-Tech Industries: A Study of R&D Partnerships in Pharmaceutical Biotechnology, Maastricht: Universitaire Pers Maastricht.
33. Scheel, C. (2002) ‘Knowledge clusters of technological innovation systems’, Journal of Knowledge Management, Vol. 6, No. 4, pp.356–367.
34. Staropoli, C. (1998) ‘Cooperation in R&D in the pharmaceutical industry – the network as an organizational innovation governing technological innovation’, Technovation, Vol. 18, No. 1, pp.13–23.
35. Strategic Direction (2002) ‘Fusing biotechnology and product innovation’, Strategic Direction, Vol. 18, No. 5, pp.25–27.
36. Szeto, E. (2000) ‘Innovation capacity: working towards a mechanism for improving innovation within an inter-organisational network’, The TQM Magazine, Vol. 12, No. 2, pp.149–158.
37. Teece, D. (1986) ‘Profiting from technological innovation: implications for integration, collaboration, licensing and public policy’, Research Policy, Vol. 15, pp.285–302.
38. Tidd, J., Bessant, J. and Pavitt, K. (1997) Managing Innovation: Integrating Technological, Market and Organizational Change, Chichester: John Wiley & Sons.
39. Van der Valk, T. (2004) ‘Partnering among biopharmaceutical companies: toward an explanatory theoretical model’. Available from: www.business.auc.dk/druid/conferences/winter2004/papers/Valk.pdf, [accessed February 2004].